nav Searchuser
Maxunitech Inc.
Beijing Multigrass Formulation Co., Ltd.

Drought Continued Impact on Bayer CropScience India's Performance of Q3 FY16qrcode

Feb. 15, 2016

Favorites Print
Feb. 15, 2016
Bayer CropScience India (BCS) posted a decline of 9% in Sales to Rs6,222 mn and 10% in total revenue to Rs 6,424 bn during Q3FY16. This compares poorly to 5% decline in Q2FY16. Growth was impacted on account of poor monsoon across the country.
Total raw material cost for the quarter declined by 9% inline with sales decline. Gross margin showed a marginal contraction of 40bps to 36.8%. However decline in sales led to lower operating efficiency and 350bps contraction in EBITDA margin. EBITDA margin for the quarter came in at 6.7% against 10.2% Q3FY15.
Interest for the quarters came in at Rs 28mn an increase of 211% yoy, while other income declined by 27% yoy basis. Overall PAT declined by 50% to Rs 274 mn.
Outlook and valuation
BCS posted disappointing performance for Q3FY16 on back of drought condition at country level. "We have cut our earning estimates by 31% & 30% to reflect the same and buyback impact. We expect BCS to post CAGR of 5% in Sales & 10% decline in PAT over FY15-17E. At Target P/E of 25x and adding surplus cash, we arrive at target price of Rs 2,302 which indicates for a huge downside of 34% from current levels. Hence we recommend Sell on stock."

Picture 0/1200

More from AgroNews


Annual Review 2019 2019 CRO & CRAO Manual
2019 Market Insight Chinese issue of 2019 Market Insight
2019 India Pesticide Suppliers Guide 2019 Biologicals Special
I wanna post a press Comment


Subscribe Email: *
Mobile Number:  


Picture 0/1200

Subscribe to daily email alerts of AgroNews.